BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2133252)

  • 21. Platelets possess functional TGF-beta receptors and Smad2 protein.
    Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
    Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olive tree wood phenolic compounds with human platelet antiaggregant properties.
    Zbidi H; Salido S; Altarejos J; Perez-Bonilla M; Bartegi A; Rosado JA; Salido GM
    Blood Cells Mol Dis; 2009; 42(3):279-85. PubMed ID: 19195914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets.
    Guinebault C; Payrastre B; Sultan C; Mauco G; Breton M; Levy-Toledano S; Plantavid M; Chap H
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):851-6. PubMed ID: 8391259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geldanamycin disrupts platelet-membrane structure, leading to membrane permeabilization and inhibition of platelet aggregation.
    Suttitanamongkol S; Gear AR; Polanowska-Grabowska R
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):307-14. PubMed ID: 10620508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free L-phosphotyrosine activates human platelets: molecular evidence for a new signal transducer.
    Munoz GE; Marshall SH
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):629-33. PubMed ID: 1282847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of human platelet protein kinase C by endotoxic lipid A.
    Grabarek J; Timmons S; Hawiger J
    J Clin Invest; 1988 Sep; 82(3):964-71. PubMed ID: 3047171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,3',5'-Triiodothyronine inhibits collagen-induced human platelet aggregation.
    Masaki H; Nishikawa M; Urakami M; Yoshimura M; Toyoda N; Mori Y; Yoshikawa N; Inada M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):721-5. PubMed ID: 1517361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ca(2+) /calmodulin-dependent kinase kinase β-AMP-activated protein kinase-α1 pathway regulates phosphorylation of cytoskeletal targets in thrombin-stimulated human platelets.
    Onselaer MB; Oury C; Hunter RW; Eeckhoudt S; Barile N; Lecut C; Morel N; Viollet B; Jacquet LM; Bertrand L; Sakamoto K; Vanoverschelde JL; Beauloye C; Horman S
    J Thromb Haemost; 2014 Jun; 12(6):973-86. PubMed ID: 24655923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on platelet protein phosphorylation in patients with impaired responses to platelet agonists.
    Speiser-Ellerton S; Weiss HJ
    J Lab Clin Med; 1990 Jan; 115(1):104-11. PubMed ID: 2105365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitors.
    Bachelot C; Cano E; Grelac F; Saleun S; Druker BJ; Levy-Toledano S; Fischer S; Rendu F
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):923-8. PubMed ID: 1622407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent.
    Sayed MR; Sheid MP; Stevens CM; Duronio V
    J Cell Physiol; 2000 Jun; 183(3):314-20. PubMed ID: 10797305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erbstatin blocks platelet activating factor-induced protein-tyrosine phosphorylation, polyphosphoinositide hydrolysis, protein kinase C activation, serotonin secretion and aggregation of rabbit platelets.
    Salari H; Duronio V; Howard SL; Demos M; Jones K; Reany A; Hudson AT; Pelech SL
    FEBS Lett; 1990 Apr; 263(1):104-8. PubMed ID: 1691984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia.
    Shibata K; Nishimura J; Yufu Y; Nawata H
    Int J Hematol; 1992 Apr; 55(2):189-96. PubMed ID: 1387329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of thrombin on phosphorylation of platelet membrane proteins.
    Steiner M
    Thromb Haemost; 1976 Jun; 35(3):635-42. PubMed ID: 989970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red wine, aspirin and platelet function.
    Rotondo S; Rotilio D; Cerletti C; de Gaetano G
    Thromb Haemost; 1996 Nov; 76(5):818-9. PubMed ID: 8950800
    [No Abstract]   [Full Text] [Related]  

  • 40. Tyrosine phosphorylation in platelets: its regulation and possible roles in platelet functions.
    Feinstein MB; Pumiglia K; Lau LF
    Adv Exp Med Biol; 1993; 344():129-48. PubMed ID: 8209782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.